Attitude and knowledge towards the effectiveness of nucleic acid-based vaccines among healthcare workers and medical students in the Jordanian population

References

• Aldosari, B. N., Alfagih, I. M., & Almurshedi, A. S. (2021). Lipid nanoparticles as delivery systems for RNA-based vaccines. Pharmaceutics, 13(2), 206. https://doi.org/10.3390/pharmaceutics13020206
   PubMed Web of Science ®Google Scholar
• Alley, S. J., Stanton, R., Browne, M., To, Q. G., Khalesi, S., Williams, S. L., Thwaite, T. L., Fenning, A. S., & Vandelanotte, C. (2021). As the pandemic progresses, how does willingness to vaccinate against covid-19 evolve? International Journal of Environmental Research and Public Health, 18(2), 797. https://doi.org/10.3390/ijerph18020797
   Web of Science ®Google Scholar
• Bloom, K., van den Berg, F., & Arbuthnot, P. (2020). Self-amplifying RNA vaccines for infectious diseases. Gene Therapy, 28(3–4), 117–12. https://doi.org/10.1038/s41434-020-00204-y
   Web of Science ®Google Scholar
• Cheng, H. Y., Jian, S. W., Liu, D. P., Ng, T. C., Huang, W. T., & Lin, H. H. (2020). High transmissibility of COVID-19 near symptom onset. medRxiv. https://doi.org/10.1101/2020.03.18.20034561
   Google Scholar
• Cross, R. (2020). Will the coronavirus help mRNA and DNA vaccines prove their worth? C&EN Glob Enterp. https://cen.acs.org/pharmaceuticals/vaccines/coronavirus-help-mRNA-DNA-vaccines/98/i14
   Google Scholar
• Gupta, R., & Morain, S. R. (2021). Ethical allocation of future COVID-19 vaccines. Journal of Medical Ethics, 47(3), 137–141. https://doi.org/10.1136/medethics-2020-106850
   Web of Science ®Google Scholar
• Ho, W., Gao, M., Li, F., Li, Z., Zhang, X. Q., & Xu, X. (2021). Next-generation vaccines: Nanoparticle-mediated DNA and mRNA delivery. Advanced Healthcare Materials, 10(8). https://doi.org/10.1002/adhm.202001812
   Google Scholar
• İkiışık, H., Sezerol, M. A., Taşçı, Y., & Maral, I. (2022, April). COVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: A cross-sectional study from Turkey. Fam Med Community Heal, 10(2). https://doi.org/10.1136/fmch-2021-001430
   Google Scholar
• Jaciubek, M., & Prasek, K. (2021). COVID-19 vaccine - Technical aspects of vaccination. Pielegniarstwo XXI Wieku, 20(1), 72–76. https://doi.org/10.2478/pielxxiw-2021-0009
   Google Scholar
• Jankowska-Polańska, B., Sarzyńska, K., Czwojdziński, E., Świątoniowska-Lonc, N., Dudek, K., & Piwowar, A. (2022). Attitude of health care workers and medical students towards vaccination against COVID-19. Vaccines [Internet].;10(4). Available from, (), 535, https://www.mdpi.com/2076-393X/10/4/535
   Web of Science ®Google Scholar
• Kallen, K. J., Heidenreich, R., Schnee, M., Petsch, B., Schlake, T., Thess, A., Baumhof, P., Scheel, B., Koch, S. D., & Fotin-Mleczek, M. (2013). A novel, disruptive vaccination technology: Self-adjuvanted RNActive ® vaccines. Human Vaccines and Immunotherapeutics, 9(10), 2263–2276. https://doi.org/10.4161/hv.25181
   PubMed Web of Science ®Google Scholar
• Kotarya, B., Pandeya, A., Khalko, R. K., Mishra, A., Priyadarshini, A., Vijaya, N., Singh, M. K., Saha, S., & Gosipatala, S. B. (2020). Prospects of sars-cov-2 vaccines and their landscape. Journal of Experimental Biology and Agricultural Sciences, 8(Spl–1–SARS–CoV–2), S246–S263. https://doi.org/10.18006/2020.8(Spl-1-SARS-CoV-2).S246.S263
   Google Scholar
• Kowalczyk, A., Doener, F., Zanzinger, K., Noth, J., Baumhof, P., Fotin-Mleczek, M., & Heidenreich, R. (2016). Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine, 34(33), 3882–3893. https://doi.org/10.1016/j.vaccine.2016.05.046
   PubMed Web of Science ®Google Scholar
• Mahase, E. (2020). Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows. Bmj. https://doi.org/10.1136/bmj.m4471
   Google Scholar
• Mehta, B., Moezinia, C. J., Jannat-Khah, D., Gibofsky, A., Tornberg, H., Pearce-Fisher, D., Goodman, S. M., Salmon, J. E., & Ibrahim, S. (2020). Hydroxychloroquine and chloroquine in COVID-19: A survey of prescription patterns among rheumatologists. JCR: Journal of Clinical Rheumatology, 26(6), 224–228. https://doi.org/10.1097/RHU.0000000000001539
   Web of Science ®Google Scholar
• Mu, Z., Haynes, B. F., & Cain, D. W. (2021). HIV mRNA vaccines—progress and future paths. Vaccines, 9(2), 134. https://doi.org/10.3390/vaccines9020134
   Web of Science ®Google Scholar
• Munavalli, G. G., Guthridge, R., Knutsen-Larson, S., Brodsky, A., Matthew, E., & Landau, M. (2021). COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: A challenging clinical conundrum in diagnosis and treatment. Archives of Dermatological Research, 314(1), 1–15. https://doi.org/10.1007/s00403-021-02190-6
   Web of Science ®Google Scholar
• Noor, A. U., Maqbool, F., Bhatti, Z. A., & Khan, A. U. (2020). Epidemiology of covid-19 pandemic: Recovery and mortality ratio around the globe. Pakistan Journal of Medical Sciences, 36(COVID19–S4). https://doi.org/10.12669/pjms.36.COVID19-S4.2660
   Google Scholar
• Okay, S., Öö, Ö., & Karahan, M. (2020). Nanoparticle-based delivery platforms for mRNA vaccine development. AIMS Biophysics, 7(4), 323–338. https://doi.org/10.3934/biophy.2020023
   Web of Science ®Google Scholar
• Papagiannis, D., Rachiotis, G., Malli, F., Papathanasiou, I. V., Kotsiou, O., Fradelos, E. C., Giannakopoulos, K., & Gourgoulianis, K. I. (2021). Acceptability of covid-19 vaccination among Greek health professionals. Vaccines, 9(3), 200. https://doi.org/10.3390/vaccines9030200
   PubMed Web of Science ®Google Scholar
• Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., Bailey, R., Swanson, K. A., Roychoudhury, S., Koury, K., Li, P., Kalina, W. V., Cooper, D., Frenck, R. W., Hammitt, L. L., … Gruber, W. C. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603–2615. https://doi.org/10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza, S., Márquez-Escobar, V. A., González-Ortega, O., Nieto-Gómez, R., & Arévalo-Villalobos, J. I. (2020). What does plant-based vaccine technology offer to the fight against COVID-19? Vaccines, 8(2), 183. https://doi.org/10.3390/vaccines8020183
   PubMed Web of Science ®Google Scholar
• Sallam, M. (2021). Covid-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines, 9(2), 160. https://doi.org/10.3390/vaccines9020160
   PubMed Web of Science ®Google Scholar
• Sandbrink, J. B., & Koblentz, G. D. (2021). Biosecurity risks associated with vaccine platform technologies. Vaccine, 40(17), 2514–2523. https://doi.org/10.1016/j.vaccine.2021.02.023
   Web of Science ®Google Scholar
• Schlick, T., Zhu, Q., Jain, S., & Yan, S. (2021). Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element. Biophysical Journal, 120(6), 1040–1053. https://doi.org/10.1016/j.bpj.2020.10.012
   Web of Science ®Google Scholar
• Sharma, A., Tiwari, S., Deb, M. K., & Marty, J. L. (2020). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. International Journal of Antimicrobial Agents, 56(2), 106054. https://doi.org/10.1016/j.ijantimicag.2020.106054
   PubMed Web of Science ®Google Scholar
• Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., & Morain, S. R. (2020). Ethical allocation of future COVID-19 vaccinesvaccine development and a potential nanomaterial path forward. Nature Nanotechnology, 47(3), 137–141. https://doi.org/10.1038/s41565-020-0737-y2021
   Google Scholar
• Singh, S., & Sharma, B. B. (2020). Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic. Lung India. https://doi.org/10.4103/lungindia.lungindia_170_20
   Google Scholar
• Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021). Factors associated with COVID-19 vaccine hesitancy. Vaccines, 9(3), 300. https://doi.org/10.3390/vaccines9030300
   Web of Science ®Google Scholar
• Szmyd, B., Bartoszek, A., Karuga, F. F., Staniecka, K., Błaszczyk, M., & Radek, M. (2021). Medical students and sars-cov-2 vaccination: Attitude and behaviors. Vaccines, 9(2), 128. https://doi.org/10.3390/vaccines9020128
   PubMed Web of Science ®Google Scholar
• Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., Kuntz, J. L., Dunnigan, K., Odean, M. J., Hegmann, K. T., Stefanski, E., Edwards, L. J., Schaefer-Solle, N., Grant, L., Ellingson, K., … Gaglani, M. (2021). Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — Eight U.S. Locations, December 2020–March. MMWR. Morbidity and Mortality Weekly Report, 70(13), 495–500. https://doi.org/10.15585/mmwr.mm7013e3
   PubMed Web of Science ®Google Scholar
• Vogel, A. B., Lambert, L., Kinnear, E., Busse, D., Erbar, S., Reuter, K. C., Wicke, L., Perkovic, M., Beissert, T., Haas, H., Reece, S. T., Sahin, U., & Tregoning, J. S. (2018). Self-Amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses. Molecular Therapy, 26(2), 446–455. https://doi.org/10.1016/j.ymthe.2017.11.017
   PubMed Web of Science ®Google Scholar
• Xing, K., X-Y, T., Liu, M., Liang, Z.-W., Chen, J.-N., J-J, L., Jiang, L.-G., Xing, F.-Q., & Jiang, Y. (2021March). Efficacy and safety of COVID-19 vaccines: A systematic review. Zhongguo Dang Dai Er Ke Za Zhi [Internet], 23(3):221–228. Available from https://pubmed.ncbi.nlm.nih.gov/33691913
   PubMedGoogle Scholar